Inhibition of Bacterial Toxin Activity by the Nuclear Stain, DRAQ5™
详细信息 查看全文
- 作者：Joshua N. Webb ; Evan Koufos ; Angela C. Brown
- 刊名：Journal of Membrane Biology
- 出版年：2016
- 出版时间：August 2016
- 年：2016
- 卷：249
- 期：4
- 页码：503-511
- 全文大小：1,596 KB
- 刊物类别：Biomedical and Life Sciences
- 刊物主题：Life Sciences
- 出版者：Springer New York
- ISSN：1432-1424
- 卷排序：249
文摘
The repeats-in-toxin family of toxins includes proteins produced by Gram negative bacteria such as Escherichia coli (α-hemolysin), Bordetella pertussis (adenylate cyclase toxin), and Aggregatibacter actinomycetemcomitans (LtxA), which contribute to the pathogenesis of these organisms by killing host cells. In the case of LtxA produced by A. actinomycetemcomitans, white blood cells are targeted, allowing the bacteria to avoid clearance by the host immune system. In its association with target cells, LtxA binds to a receptor, lymphocyte function-associated antigen-1, as well as membrane lipids and cholesterol, before being internalized via a lysosomal-mediated pathway. The motivation for this project comes from our discovery that DRAQ5™, a membrane-permeable nuclear stain, prevents the internalization of LtxA in a Jurkat T cell line. We hypothesized that DRAQ5™, in crossing the plasma membrane, alters the properties of the membrane to inhibit LtxA internalization. To investigate how DRAQ5™ interacts with the lipid membrane to prevent LtxA internalization, we used studied DRAQ5™-mediated membrane changes in model membranes using a variety of techniques, including differential scanning calorimetry and fluorescence spectroscopy. Our results suggest that DRAQ5™ inhibits the activity of LtxA by decreasing the fluidity of the cellular lipid membrane, which decreases LtxA binding. These results present an interesting possible anti-virulence strategy; by altering bacterial toxin activity by modifying membrane fluidity, it may be possible to inhibit the pathogenicity of A. actinomycetemcomitans.KeywordsBacterial toxinMembrane fluidityVirulenceAnthracycline